1. Home
  2. FTFT vs NNVC Comparison

FTFT vs NNVC Comparison

Compare FTFT & NNVC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Future FinTech Group Inc.

FTFT

Future FinTech Group Inc.

HOLD

Current Price

$1.20

Market Cap

22.0M

ML Signal

HOLD

NNVC

NanoViricides Inc.

HOLD

Current Price

$1.21

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FTFT
NNVC
Founded
N/A
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
22.0M
24.8M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
FTFT
NNVC
Price
$1.20
$1.21
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
122.2K
403.1K
Earning Date
11-14-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,665,719.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$133.33
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.01
$0.94
52 Week High
$5.00
$2.23

Technical Indicators

Market Signals
Indicator
FTFT
NNVC
Relative Strength Index (RSI) 36.05 38.93
Support Level $1.04 $1.16
Resistance Level $1.20 $1.28
Average True Range (ATR) 0.12 0.15
MACD 0.02 -0.04
Stochastic Oscillator 30.21 6.32

Price Performance

Historical Comparison
FTFT
NNVC

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and a cryptocurrency mining farm in the U.S. The company's reportable segments include asset management services, supply chain financing and trading, and others.

About NNVC NanoViricides Inc.

Nanoviricides Inc is a nano-biopharmaceutical company that is engaged in discovering, developing, and commercializing therapeutics to advance the care of patients suffering from life-threatening viral infections. The company engaged in the application of nanomedicine technologies to the complex issues of viral diseases. It focuses its research and clinical programs on specific anti-viral therapeutics and is seeking to add to its existing portfolio of products through its internal discovery and clinical development programs and through in-licensing.

Share on Social Networks: